Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Praprotnik

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Arthritis and Rheumatism|April 22, 1999
Is malignant infiltration necessary for development of leukemic arthritis? Comment on the article by Rudwaleit et alS Praprotnik, M Tomsic
Clinical Rheumatology|May 1, 1996
A decrease in antiphospholipid antibodies before a thrombotic eventS Praprotnik, B Bozic
Lupus|October 1, 1995
Ovaries in systemic lupus erythematosusS Praprotnik, J Prezelj
British Journal of Rheumatology|February 11, 1999
Unusual occurrence of acute low back pain in a patient with ruptured urachal cystA Ambrozic, S Praprotnik, B Rozman
Annals of the Rheumatic Diseases|April 19, 2005
New issues in tuberculosisS Praprotnik, B Rozman, M Tomsic
Clinical and Experimental Rheumatology|March 20, 1999
Fluctuation of anti-Ro/SS-A antibody levels in patients with systemic lupus erythematosus and Sjögren's syndrome: a prospective studyS Praprotnik, B Bozic, T Kveder, et al.
Clinical and Experimental Rheumatology|January 17, 2002
Is Sjögren's syndrome involved in the formation of localised nodular amyloidosis?S Praprotnik, M Tomsic, T Perkovic, et al.
Wiener Klinische Wochenschrift|October 6, 2000
Pathogenic role of anti-endothelial cell antibodies in systemic vasculitisS Praprotnik, B Rozman, M Blank, et al.
Lupus|July 26, 2005
Azathioprine induced hepatic veno-occlusive disease in systemic lupus erythematosusS Praprotnik, A Hocevar, V Ferlan-Marolt, et al.
The Pharmacogenomics Journal|May 25, 2016
Clinical-pharmacogenetic predictive models for MTX discontinuation due to adverse events in rheumatoid arthritisB Jenko, L Lusa, M Tomsic, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Arthritis and Rheumatism|April 22, 1999
Is malignant infiltration necessary for development of leukemic arthritis? Comment on the article by Rudwaleit et alS Praprotnik, M Tomsic
Clinical Rheumatology|May 1, 1996
A decrease in antiphospholipid antibodies before a thrombotic eventS Praprotnik, B Bozic
Lupus|October 1, 1995
Ovaries in systemic lupus erythematosusS Praprotnik, J Prezelj
British Journal of Rheumatology|February 11, 1999
Unusual occurrence of acute low back pain in a patient with ruptured urachal cystA Ambrozic, S Praprotnik, B Rozman
Annals of the Rheumatic Diseases|April 19, 2005
New issues in tuberculosisS Praprotnik, B Rozman, M Tomsic
Clinical and Experimental Rheumatology|March 20, 1999
Fluctuation of anti-Ro/SS-A antibody levels in patients with systemic lupus erythematosus and Sjögren's syndrome: a prospective studyS Praprotnik, B Bozic, T Kveder, et al.
Clinical and Experimental Rheumatology|January 17, 2002
Is Sjögren's syndrome involved in the formation of localised nodular amyloidosis?S Praprotnik, M Tomsic, T Perkovic, et al.
Wiener Klinische Wochenschrift|October 6, 2000
Pathogenic role of anti-endothelial cell antibodies in systemic vasculitisS Praprotnik, B Rozman, M Blank, et al.
Lupus|July 26, 2005
Azathioprine induced hepatic veno-occlusive disease in systemic lupus erythematosusS Praprotnik, A Hocevar, V Ferlan-Marolt, et al.
The Pharmacogenomics Journal|May 25, 2016
Clinical-pharmacogenetic predictive models for MTX discontinuation due to adverse events in rheumatoid arthritisB Jenko, L Lusa, M Tomsic, et al.
Pageof 4